M. Maccario et al., MAXIMAL SECRETORY CAPACITY OF SOMATOTROPE CELLS IN OBESITY - COMPARISON WITH GH DEFICIENCY, International journal of obesity, 21(1), 1997, pp. 27-32
OBJECTIVE: To evaluate the maximal secretory capacity of somatotrope c
ells in obesity and to compare it with that in hypopituitaric patients
with GH deficiency. DESIGN: Stimulation with GHRH. (1 mu g/kg iv) com
bined with arginine (ARG, 0.5 g/kg iv), which strongly potentiates the
GH response to the neurohormone, likely inhibiting hypothalamic somat
ostatin. The reproducibility of the GH response to GHRH + ARG was eval
uated in a second session. SUBJECTS: Forty-five patients with simple o
besity (OB 11 male and 34 female, age 40.5+/-1.8y, BMI 38.8 +/- 1.1 kg
/m(2)), 49 patients with hypopituitarism (GHD, 23 male and 26 female,
43.6 +/- 2.4y, 24.7+/-0.7 kg/m(2)) and 44 normal young volunteers (NS,
25 male and 19 female, 33.8+/-1.0y, 21.6+/-0.3 kg/m(2)) were studied,
MEASUREMENTS: GH levels were assayed by IRMA method, basally at - 60
and 0 min, and than every 15 min up to + 120 min. Basal IGF-I levels w
ere assayed by RIA method, after acid-ethanol extraction. RESULTS: IGF
-I levels in OB were lower (P<0.005) than those in NS but higher (P<0.
005) than those in GHD. Mean peak GH response to GHRH+ARG in OB was cl
early lower than that in NS (P<0.005) and higher (P<0.005) than that i
n GHD. Sixty-percent OB and 100% GHD showed peak GH responses lower th
an the minimum normal limit in NS (16.5 mu g/l) while 4% OB and only 5
3% GHD with GH responses lower than 3 mu g/l, the limit under which GH
replacement therapy of severe deficiency is allowed. Good intraindivi
dual reproducibility of the GH response to GHRH + arginine test was pr
esent in all groups (OB: r=0.78, P<0.0001; GHD: r=0.57, P<0.003; NS: r
=0.74, P<0.0001;. CONCLUSIONS: The maximal secretory capacity of somat
otrope cells is clearly less than normal in the obese but still more t
han is seen in GHD subjects. However, in about 50% of obese patients,
the pituitary GH releasable pool overlaps with that of hypopituitaric
patients with GH deficiency. Thus, even when the maximal secretory cap
acity of somatotrope cells is evaluated by a potent and reproducible p
rovocative tests such as GHRH + arginine, overweight has to be taken i
n a great account as the cause of severely impaired GH response in pat
ients with suspected GH deficiency.